Skip to Main Content

Author Details

Jeremy A Rassen
Brigham and Women's Hospital, Harvard Medical School
2006
82
37
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36349471High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting.Pharmacoepidemiol Drug Saf2023
37428347Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer.Target Oncol2023
36528788Scalable Feature Engineering from Electronic Free Text Notes to Supplement Confounding Adjustment of Claims-Based Pharmacoepidemiologic Studies.Clin Pharmacol Ther2023
34726771The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications.Clin Pharmacol Ther2022
35373865Categorization of COVID-19 severity to determine mortality risk.Pharmacoepidemiol Drug Saf2022
35984046Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting.Pharmacoepidemiol Drug Saf2022
35297969Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge.JAMA Netw Open2022
33293424Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study.CMAJ2021
33852197Reply to the Letter by Arterburn D. et al. ("Bias in EHR-based studies: Seeing the Forest for the Trees").Diabetes Obes Metab2021
33625463Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.JAMA Intern Med2021
33566434Real-world evidence of bariatric surgery and cardiovascular benefits using electronic health records data: A lesson in bias.Diabetes Obes Metab2021
33730088COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.PLoS One2021
33529354Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19.Clin Pharmacol Ther2021
34156310Single-arm oncology trials and the nature of external controls arms.J Comp Eff Res2021
33099844Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS).Pharmacoepidemiol Drug Saf2021
32533499Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile.Drugs Real World Outcomes2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33354682Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection.medRxiv2020
32524701Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS).Pharmacoepidemiol Drug Saf2020
32133717Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project.Pharmacoepidemiol Drug Saf2020
30856654Graphical Depiction of Longitudinal Study Designs in Health Care Databases.Ann Intern Med2019
31778623Actionable Real-World Evidence to Improve Health Outcomes and Reduce Medical Spending Among Risk-Stratified Patients with Diabetes.J Manag Care Spec Pharm2019
30588119Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases.Clin Epidemiol2018
29958191Erratum: High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data.Epidemiology2018
27779497Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases.Epidemiology2017
28397352Effects of expanding the look-back period to all available data in the assessment of covariates.Pharmacoepidemiol Drug Saf2017
28964431Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.Value Health2017
28913963Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.Pharmacoepidemiol Drug Saf2017
26690726Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.Clin Pharmacol Ther2016
25488047High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.Stat Med2015
26188765Selective Serotonin Reuptake Inhibitor Use and Perioperative Bleeding and Mortality in Patients Undergoing Coronary Artery Bypass Grafting: A Cohort Study.Drug Saf2015
26234275The next frontier: Fostering innovation by improving health data access and utilization.Clin Pharmacol Ther2015
25935198Incorporating linked healthcare claims to improve confounding control in a study of in-hospital medication use.Drug Saf2015
24240651Prospective cohort studies of newly marketed medications: using covariate data to inform the design of large-scale studies.Epidemiology2014
25076153Optimal matching ratios in drug safety surveillance.Epidemiology2014
24788694A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment.Pharmacoepidemiol Drug Saf2014
24587587Plasmode simulation for the evaluation of pharmacoepidemiologic methods in complex healthcare databases.Comput Stat Data Anal2014
24510605Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrel.Drug Saf2014
24323618Metrics for covariate balance in cohort studies of causal effects.Stat Med2014
23155221Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist.Ann Rheum Dis2013
24052582Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study.BMJ2013
23885678Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs.Am J Med2013
23752258Confounding adjustment in comparative effectiveness research conducted within distributed research networks.Med Care2013
23532053Matching by propensity score in cohort studies with three treatment groups.Epidemiology2013
23541855Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.J Thorac Cardiovasc Surg2013
23021799Emerging analytical techniques for comparative effectiveness research.Am J Kidney Dis2013
22162077Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses.Pharmacoepidemiol Drug Saf2012
24237367Newly marketed medications present unique challenges for nonrandomized comparative effectiveness analyses.J Comp Eff Res2012
23181419Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments.BMC Med Res Methodol2012
22711757Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes.Eur Heart J2012
  • 1 - 50 of 82

Recommended Authors

Clair Blacketer
Erasmus University Medical Center
Career Start Year 2016
Number of shared co-authors 2
James R Rogers
Columbia University
Career Start Year 2015
Number of shared co-authors 8
Zach Shahn
CUNY School of Public Health
Career Start Year 2014
Number of shared co-authors 2
Erica A Voss
Erasmus University Medical Center
Career Start Year 2014
Number of shared co-authors 2
Lana Y H Lai
The University of Manchester, University of Manchester
Career Start Year 2013
Number of shared co-authors 3
Justin Bohn
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2012
Number of shared co-authors 5
Rishi J Desai
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 10
Orestis A Panagiotou
Department of Health Services, Brown University School of Public Health
Career Start Year 2010
Number of shared co-authors 0
Azza Shoaibi
Janssen Pharmaceutical Research and Development
Career Start Year 2010
Number of shared co-authors 2
Dylan S Small
University of Pennsylvania
Career Start Year 2006
Number of shared co-authors 1
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 4
Robert A Greevy
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 4
Michele Jonsson Funk
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 3
Qingxia Chen
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 1
Nilay D Shah
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 2
Joseph S Ross
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 3
Lesley H Curtis
Duke Clinical Research Institute
Career Start Year 1999
Number of shared co-authors 9
Nicole L Pratt
Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
Career Start Year 1998
Number of shared co-authors 8
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 0
Jonathan S Schildcrout
Vanderbilt University Medical Center.
Career Start Year 1997
Number of shared co-authors 0
Alistair J O'Malley
The Dartmouth Institute, Geisel School of Medicine at Dartmouth
Career Start Year 1997
Number of shared co-authors 0
Manisha Desai
Stanford University
Career Start Year 1997
Number of shared co-authors 1
Patrick J Heagerty
University of Washington
Career Start Year 1992
Number of shared co-authors 10
Todd A MacKenzie
Geisel School of Medicine at Dartmouth
Career Start Year 1992
Number of shared co-authors 0
David Madigan
Columbia University.
Career Start Year 1990
Number of shared co-authors 5
Sharon-Lise T Normand
Harvard Medical School
Career Start Year 1988
Number of shared co-authors 2
Jesse A Berlin
Rutgers University School of Public Health
Career Start Year 1988
Number of shared co-authors 7
Mark G Weiner
Weill Cornell Medical College
Career Start Year 1987
Number of shared co-authors 5
Muhammad Mamdani
Institute of Health Policy, University of Toronto
Career Start Year 1984
Number of shared co-authors 2
Elizabeth A Chrischilles
University of Iowa, School of Public Health
Career Start Year 1982
Number of shared co-authors 7

Collaborators

Sebastian Schneeweiss
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Co-authored papers 61
Joshua J Gagne
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Co-authored papers 19
Shirley V Wang
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 7
Jeffrey S Brown
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 5
Soko Setoguchi
Rutgers University Institute for Health, the State University of New Jersey
Co-authored papers 3
Nicolas H Thurin
INSERM CIC-P 1, Bordeaux PharmacoEpi, Universite de Bordeaux
Co-authored papers 3
Marie R Griffin
Vanderbilt University Medical Center
Co-authored papers 3
Sengwee Toh
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 3
Alexander M Walker
Harvard T.H. Chan School of Public Health
Co-authored papers 3
Martijn J Schuemie
University of California los angeles
Co-authored papers 3
Norman E Sharpless
National Cancer Institute
Co-authored papers 2
Lynne Penberthy
National Cancer Institute
Co-authored papers 2
Miriam C J M Sturkenboom
University Medical Center Utrecht
Co-authored papers 2
Douglas R Lowy
Co-authored papers 2
Michael Nguyen
Center for Drug Evaluation and Research
Co-authored papers 2
Olaf H Klungel
Co-authored papers 2
Hannes Braberg
University of California San Francisco
Co-authored papers 1
Zun Zar Chi Naing
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
Jiewei Xu
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Nadia Herrera
University of California san francisco
Co-authored papers 1
Ming Sun
Columbia University
Co-authored papers 1
Loan Doan
University of California san francisco
Co-authored papers 1
Maliheh Safari
University of California san francisco
Co-authored papers 1
Anthony J Hodder
University of Sheffield
Co-authored papers 1
Justin T Biel
University of California san francisco
Co-authored papers 1
Ishan Deshpande
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Fengbo Zhou
Washington University School of Medicine
Co-authored papers 1
David E Gordon
Emory University
Co-authored papers 1
Tristan W Owens
University of California san francisco
Co-authored papers 1
Thomas Kehrer
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Release 1.2